Module 1 References

1. Finer, L. B., & Zolna, M. R. (2016). Declines in Unintended Pregnancy in the United States, 2008-2011. The New England journal of medicine, 374(9), 843–852.
https://doi.org/10.1056/NEJMsa1506575.
 
2. Heil, S. H., Jones, H. E., Arria, A., Kaltenbach, K., Coyle, M., Fischer, G., Stine, S.,
Selby, P., & Martin, P. R. (2011). Unintended pregnancy in opioid-abusing women.
Journal of substance abuse treatment, 40(2), 199–202.
https://doi.org/10.1016/j.jsat.2010.08.011.
 
3. Terplan, M., Hand, D. J., Hutchinson, M., Salisbury-Afshar, E., & Heil, S. H. (2015). Contraceptive use and method choice among women with opioid and other substance
use disorders: A systematic review. Preventive medicine, 80, 23–31.
https://doi.org/10.1016/j.ypmed.2015.04.008.
 
4. Centers for Disease Control and Prevention. An Alcohol-Free Pregnancy is the Best
Choice For Your Baby [Brochure].
https://www.cdc.gov/ncbddd/fasd/documents/fasdbrochure_final.pdf.
 
5. Substance Abuse and Mental Health Services Administration. (2020, November 18).
2019 National Survey on Drug Use and Health: Women. SAMHSA.
https://www.samhsa.gov/data/report/2019-nsduh-women.

6. Centers for Disease Control and Prevention. National Center for Health Statistics.
National Health Interview Survey 1965-2018. Analysis for years 1997-2018 by the
American Lung Association Research Team using SPSS software.
 
7. Substance Abuse and Mental Health Services Administration. (2020, November 18).
2019 National Survey on Drug Use and Health: Women, 8. SAMHSA.
https://www.samhsa.gov/data/report/2019-nsduh-women.

8. Substance Abuse and Mental Health Services Administration. (2020, November 18).
2019 National Survey on Drug Use and Health: Women, 25. SAMHSA.
https://www.samhsa.gov/data/report/2019-nsduh-women.

Module 2 References

1. Georgia Department of Public Health. (2019). Opioid Overdose Surveillance
Preliminary Report Georgia – 2019, 7. Georgia Department of Public Health.
https://dph.georgia.gov/opioid-overdose-annual-surveillance.
 
2. Georgia Department of Public Health. (2019). Opioid Overdose Surveillance
Preliminary Report Georgia – 2019, 12. Georgia Department of Public Health.
https://dph.georgia.gov/opioid-overdose-annual-surveillance.

3. Georgia Department of Public Health. (2019). Opioid Overdose Surveillance
Preliminary Report Georgia – 2019, 2. Georgia Department of Public Health.
https://dph.georgia.gov/opioid-overdose-annual-surveillance.

4. Georgia Department of Public Health. (2019). Opioid Overdose Surveillance
Preliminary Report Georgia – 2019, 17. Georgia Department of Public Health.
https://dph.georgia.gov/opioid-overdose-annual-surveillance.

5. Georgia Department of Public Health. (2019). Opioid Overdose Surveillance
Preliminary Report Georgia – 2019, 10. Georgia Department of Public Health.
https://dph.georgia.gov/opioid-overdose-annual-surveillance.

6. Georgia Department of Public Health. (2019). Opioid Overdose Surveillance
Preliminary Report Georgia – 2019, 15. Georgia Department of Public Health.
https://dph.georgia.gov/opioid-overdose-annual-surveillance.

7. Gladden, R. M., O’Donnell, J., Mattson, C. L., & Seth, P. (2019, August 29). Changes
in Opioid-Involved Overdose Deaths by Opioid Type and Presence of Benzodiazepines, Cocaine, and Methamphetamine - 25 States, July–December 2017 to January–June 2018. Centers for Disease Control and Prevention.
https://www.cdc.gov/mmwr/volumes/68/wr/mm6834a2.htm.

8. Patrick, S. W., Schumacher, R. E., Benneyworth, B. D., Krans, E. E., McAllister, J. M., & Davis, M. M. (2012). Neonatal Abstinence Syndrome and Associated Health Care Expenditures.
JAMA, 307(18), 1934–1940.
https://doi.org/10.1001/jama.2012.3951.

9. Jones, H. E., Harrow, C., O’Grady, K. E., Crocetti, M., Jansson, L. M., & Kaltenbach, K.
(2010). Neonatal abstinence scores in opioid-exposed and nonexposed neonates: a
blinded comparison. Journal of opioid management, 6(6), 409–413.
https://doi.org/10.5055/jom.2010.0038.
 
10. Neonatal Abstinence Syndrome (NAS) Clinic. Johns Hopkins All Children’s Hospital. (n.d.).
https://www.hopkinsallchildrens.org/Services/Maternal-Fetal-Neonatal-Institute/Neonatal-Follow-Up-Program/Neonatal-Abstinence-Syndrome-Follow-Up-Clinic.
 
11. Vanderbilt University Medical Center Podcast: New approaches to Neonatal Abstinence Syndrome. American Hospital Association. (n.d.).
https://www.aha.org/advancing-health-podcast/2019-04-17-vanderbilt-university-medical-center-podcast-new-approaches.

12. Georgia Department of Public Health. (2017). Neonatal Abstinence Syndrome: Annual Surveillance Report – 2017, 11. Georgia Department of Public Health.
https://dph.georgia.gov/NAS.
 
13. Georgia Hospital Discharge Data (2007-2017). Georgia Department of Public Health,
Office of Health Indicators for Planning. Data pulled October 25, 2018.
 
14. Georgia Department of Public Health. (2017). Neonatal Abstinence Syndrome: Annual Surveillance Report – 2017, 8. Georgia Department of Public Health.
https://dph.georgia.gov/NAS.

15. Georgia Department of Public Health. (2017). Neonatal Abstinence Syndrome: Annual Surveillance Report – 2017, 17. Georgia Department of Public Health.
https://dph.georgia.gov/NAS.
 
16. State Electronic Notifiable Disease Surveillance System NAS reporting form (2017).
Georgia Department of Public Health. Data pulled September 5, 2018.
 
17. Georgia Department of Public Health. (2016). Neonatal Abstinence Syndrome: Annual Surveillance Report – 2016, 16. Georgia Department of Public Health.
https://dph.georgia.gov/NAS.

Module 3 References

1. University of Connecticut. (2019, July 23). Alcohol, Other Substance Use, & Support.
Student Health and Wellness.
https://studenthealth.uconn.edu/alcohol-substance-support.
 
2. Recovery Research Institute. (n.d.). Special Topics and Resources. Recovery
Research Institute.
https://www.recoveryanswers.org/resource/guide-drinking-levels.
 
3. Centers for Disease Control and Prevention. (2021, May 14). State-Level Estimates of
Alcohol Use Among Women – 2019. Centers for Disease Control and Prevention.
https://www.cdc.gov/ncbddd/fasd/data-maps-2019.html.
 
4. U.S. Department of Health and Human Services, National Institute of Health, National
Institute on Alcohol Abuse and Alcoholism. (n.d.). What are the Consequences? .
Rethinking Drinking.
https://www.rethinkingdrinking.niaaa.nih.gov/How-much-is-too-much/Whats-the-harm/What-Are-The-Consequences.aspx.
 
5. Substance Abuse and Mental Health Services Administration. (2020, September). Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health. SAMHSA.
https://www.samhsa.gov/data/report/2019-nsduh-annual-national-report.

6. Vishnu Tewari, V., Mehta, R., & Tewari, K. (2016). Dysmorphic Neonate: An approach to diagnosis in the current era. Pediatric Dimensions, 1(1), 8–14.
https://doi.org/10.15761/pd.1000102
 
7. Centers for Disease Control and Prevention. An Alcohol-Free Pregnancy is the Best Choice For Your Baby [Brochure].
https://www.cdc.gov/ncbddd/fasd/documents/fasdbrochure_final.pdf

8. Centers for Disease Control and Prevention. (2021, May 21). Fetal Alcohol Spectrum Disorders (FASDs) - Basics. Centers for Disease Control and Prevention.
https://www.cdc.gov/ncbddd/fasd/facts.html.

Module 4 References

1. Substance Abuse and Mental Health Services Administration. (2020, November 18). 2019 National Survey on Drug Use and Health: Women, 8. SAMHSA.
https://www.samhsa.gov/data/report/2019-nsduh-women.
 
2. Navarrete, F., García-Gutiérrez, M. S., Gasparyan, A., Austrich-Olivares, A., Femenía, T., & Manzanares, J. (2020). Cannabis Use in Pregnant and Breastfeeding Women: Behavioral and Neurobiological Consequences. Frontiers in psychiatry, 11, 586447.
https://doi.org/10.3389/fpsyt.2020.586447.
 
3. Alpár, A., Di Marzo, V., & Harkany, T. (2016). At the Tip of an Iceberg: Prenatal Marijuana and Its Possible Relation to Neuropsychiatric Outcome in the Offspring. Biological psychiatry, 79(7), e33–e45. https://doi.org/10.1016/j.biopsych.2015.09.009.

4. Centers for Disease Control and Prevention. (2020, November 25). Polysubstance Use in Pregnancy. Centers for Disease Control and Prevention.
https://www.cdc.gov/pregnancy/polysubstance-use-in-pregnancy.html.
 
5. U.S. Department of Health & Human Services. (2019, August 29). U.S. Surgeon General’s Advisory: Marijuana Use and the Developing Brain. Office of the Surgeon General.
https://www.hhs.gov/surgeongeneral/reports-and-publications/addiction-and-substance-misuse/advisory-on-marijuana-use-and-developing-brain/index.html.
 
6. Leemaqz, S. Y., Dekker, G. A., McCowan, L. M., Kenny, L. C., Myers, J. E., Simpson, N. A., Poston, L., Roberts, C. T., & SCOPE Consortium (2016). Maternal marijuana use has independent effects on risk for spontaneous preterm birth but not other common late pregnancy complications. Reproductive toxicology (Elmsford, N.Y.), 62, 77–86.
https://doi.org/10.1016/j.reprotox.2016.04.021.
 
7. Committee opinion No. 722: Marijuana Use During Pregnancy and Lactation. (2017).
American College of Obstetrics & Gynecology, 130(4).
https://doi.org/10.1097/aog.0000000000002354
 
8. Coleman-Cowger, V. H., Oga, E. A., Peters, E. N., & Mark, K. (2018). Prevalence and associated birth outcomes of co-use of Cannabis and tobacco cigarettes during pregnancy. Neurotoxicology and teratology, 68, 84–90.
https://doi.org/10.1016/j.ntt.2018.06.001.
 
9. Gunn, J. K., Rosales, C. B., Center, K. E., Nuñez, A., Gibson, S. J., Christ, C., & Ehiri, J. E. (2016). Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ open, 6(4), e009986.
https://doi.org/10.1136/bmjopen-2015-009986.
 
10. Ryan, S. A., Ammerman, S. D., & O’Connor, M. E. (2018). Marijuana Use During Pregnancy
and Breastfeeding: Implications for Neonatal and Childhood Outcomes. Pediatrics, 142(3).
https://doi.org/10.1542/peds.2018-1889.

11. Lo, J. O., Hanna, C. B., Hedges, J. C. (2021). Effects of marijuana use on female reproductive health and pregnancy. Contemporary OB/GYN Journal, 66(10), 24–30.

12. Conner, S. N., Bedell, V., Lipsey, K., Macones, G. A., Cahill, A. G., & Tuuli, M. G. (2016). Maternal marijuana use and adverse neonatal outcomes. Obstetrics & Gynecology, 128(4), 713–723. https://doi.org/10.1097/aog.0000000000001649

13. Corsi, D. J., Donelle, J., Sucha, E., Hawken, S., Hsu, H., El-Chaâr, D., Bisnaire, L., Fell, D., Wen, S. W., & Walker, M. (2020). Maternal cannabis use in pregnancy and child neurodevelopmental outcomes. Nature Medicine, 26(10), 1536–1540. https://doi.org/10.1038/s41591-020-1002-5

Module 5 References

1. Substance Abuse and Mental Health Services Administration. (2016, September). Key Substance Use and Mental Health Indicators in the United States: Results from the 2015 National Survey on Drug Use and Health: Detailed Tables. SAMHSA. 2016.
 
2. Song, A. V., Morrell, H. E., Cornell, J. L., Ramos, M. E., Biehl, M., Kropp, R. Y., &
Halpern-Felsher, B. L. (2009). Perceptions of smoking-related risks and benefits as predictors
of adolescent smoking initiation. American journal of public health, 99(3), 487–492.
https://doi.org/10.2105/AJPH.2008.137679.
 
3. Centers for Disease Control and Prevention. (2020, December 10). Current Cigarette
Smoking Among Adults in the United States. Smoking & Tobacco Use.
https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/index.htm.
 
4. Centers for Disease Control and Prevention. (2021, February 11). Pregnant or Planning
to Have a Baby. Centers for Disease Control and Prevention.
https://www.cdc.gov/tobacco/campaign/tips/groups/pregnant-planning.html.
 
5. Lambers, D. S., & Clark, K. E. (1996). The maternal and fetal physiologic effects of nicotine. Seminars in perinatology, 20(2), 115–126.
https://doi.org/10.1016/s0146-0005(96)80079-6.
 
6. Stark, C. J., & Stepans, M. B. (2004). A comparison of blood pressure in term, low birth-weight infants of smoking and nonsmoking mothers. The Journal of perinatal education, 13(4), 17–26. https://doi.org/10.1624/105812404X6199.
 
7. Centers for Disease Control and Prevention. (2021, May 12). Smoking, Pregnancy, and Babies. Centers for Disease Control and Prevention.
https://www.cdc.gov/tobacco/campaign/tips/diseases/pregnancy.html#six.
 
8. Han, J. Y., Kwon, H. J., Ha, M., Paik, K. C., Lim, M. H., Gyu Lee, S., Yoo, S. J., & Kim, E. J. (2015). The effects of prenatal exposure to alcohol and environmental tobacco smoke on risk for ADHD: a large population-based study. Psychiatry research, 225(1-2), 164–168.
https://doi.org/10.1016/j.psychres.2014.11.009.
 
9. Huang, L., Wang, Y., Zhang, L., Zheng, Z., Zhu, T., Qu, Y., & Mu, D. (2018). Maternal smoking and attention-deficit/hyperactivity disorder in offspring: A meta-analysis. Pediatrics, 141(1).
https://doi.org/10.1542/peds.2017-2465.
 
10. U.S. Department of Health and Human Services, the Office of the U.S Surgeon General and
the U.S. Centers for Disease Control and Prevention, Office on Smoking and Health. (2021). Get the Facts on E-cigarettes. Know the Risks: E-cigarettes & Young People.
https://e-cigarettes.surgeongeneral.gov/getthefacts.html.
 
11. U.S. Department of Health and Human Services, the Office of the U.S Surgeon General and
the U.S. Centers for Disease Control and Prevention, Office on Smoking and Health. (2021). Know the Risks. Know the Risks: E-cigarettes & Young People.
https://e-cigarettes.surgeongeneral.gov/knowtherisks.html.
 
12. Quiroga, L., Asif, M., Lagziel, T., Bhat, D., & Caffrey, J. (2019). E-Cigarette Battery
Explosions: Review of the Acute Management of the Burns and the Impact on Our
Population. Cureus, 11(8), e5355.
https://doi.org/10.7759/cureus.5355.